Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Leading New Trends & Stimulating New Vitality, HNC Shenzhen 2023 Came to a Satisfactory Close. See You in Shanghai in 2024. 2024-01-05 10:10
Therabody, the Global Leader In Wellness Technology, Defends Against Recent Patent Infringement Lawsuit Filed by Hyperice 2024-01-05 06:33
Greenway Health Earns Frost & Sullivan's 2023 North American Revenue Cycle Management Customer Value Leadership Award for Consistently Delivering Products and Services that Enhance Health Providers and Patients Experiences 2024-01-05 04:30
Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications 2024-01-05 00:19
JW Therapeutics Announces NMPA Acceptance of the Supplemental Biological License Application for Carteyva® in Patients with Relapsed or Refractory Mantle Cell Lymphoma 2024-01-04 21:40
OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing to Advance Portfolio of Assets for Cancer Patients 2024-01-04 21:11
Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA 2024-01-04 21:05
Avenzo Therapeutics Announces Global License of AVZO-021 (ARTS-021), a Potentially Best-in-Class Clinical Stage CDK2 Inhibitor from Allorion Therapeutics 2024-01-04 21:02
GenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare Sector 2024-01-04 17:37
GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry 2024-01-04 16:55
Laekna Announces Poster Presentation on Internally-Discovered Antibody for NASH/Liver Fibrosis at NASH-TAG 2024 2024-01-04 12:40
Telix to Present at the 42nd Annual J.P. Morgan Healthcare Conference 2024-01-04 06:20
IASO BIO Announces New Development Partnership with Umoja Biopharma to Develop Ex Vivo and In Vivo Cell and Gene Therapies 2024-01-04 05:30
GPN Vaccines Reports Positive Safety and Immunogenicity Data from its Phase 1 Trial of Gamma-PN 2024-01-04 04:30
Mr. Chong-Yoon Lim, Chairman of COREE Group emphasizes "Creative destruction and Healthcare 4.0" [New Year Message at X-Twitter SNS] 2024-01-03 22:00
Turn Biotechnologies' Expanded eTurna™ Delivery Platform Designed to Solve Delivery and Targeting Issues that Challenge Industry 2024-01-03 22:00
Brii Biosciences Appoints Dr. Brian Alvin Johns as Chief Scientific Officer 2024-01-03 20:00
Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases 2024-01-03 19:37
Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A 2024-01-03 18:10
Artificial Intelligence helps predict falls, creating safety system for patients 2024-01-03 16:00
1 48 49 50 51 52 1502